ArticleCancer communications (London, England)2024

Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3.

Bianca Cesaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.